Hossein Borghaei, MD of Fox Chase Discusses new data on lurbinectedin

PharmaMar will submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD of Fox Chase discusses the new data released and what advantages ... Author: PharmaMar Added: 08/21/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts